# DESCRIPTION

## TECHNICAL FIELD

- relate to composition for amelioration of obesity

## BACKGROUND ART

- describe obesity and its consequences

## DISCLOSURE

### Technical Problem

- identify need for obesity treatment without side effects

### Technical Solution

- provide composition containing phospholipase A2 for obesity prevention or treatment

### Advantageous Effects

- describe benefits of composition containing phospholipase A2

## DETAILED DESCRIPTION OF THE INVENTION

- define phospholipase A2 and its effects
- describe obesity and its causes
- explain administration of composition containing phospholipase A2
- describe pharmaceutical composition and its preparation
- describe health functional food composition and its preparation
- describe feed composition and its preparation
- describe method for preventing or treating obesity

### MODE FOR CARRYING OUT THE INVENTION

- describe test examples for evaluating effects of phospholipase A2

### Test Example 1: Increase in Anti-Inflammatory Macrophages by bvPLA2

- describe test example for evaluating increase in anti-inflammatory macrophages

### Test Example 2: Alleviation of Inflammatory Environment by bvPLA2

- describe test example for evaluating alleviation of inflammatory environment

### Test Example 3: Oil Red O Staining

- describe test example for evaluating oil red O staining

### Test Example 4: Experimental Animals

- describe experimental animals used in test examples

### Test Example 5: Regulatory T Cell Depletion (Treg Depletion)

- describe test example for evaluating regulatory T cell depletion

### Test Example 6: Quantitative Real-Time PCR

- describe test example for evaluating quantitative real-time PCR

### Test Example 7: H&E Staining

- describe test example for evaluating H&E staining

### Test Example 8: Statistical Analysis

- describe statistical analysis of test results

## Example 1: Effects of bvPLA2 of Reducing Adipose Tissue Weight and Body Weight

- describe effects of bvPLA2 on reducing adipose tissue weight and body weight

## Example 2: Influence of bvPLA2 on Body Weight and Adipose Tissue Weight of CD206-Deficient and Regulatory T Cell-Deficient Mice

- investigate immunoregulatory effect of bvPLA2

## Example 3: Hepatotoxicity/Nephrotoxicity Reducing Effects of bvPLA2

### Example 3-1: Effects of bvPLA2 of Ameliorating Hepatic Steatosis and Kidney Damage

- investigate PLA2 alleviating HFD-induced hepatic steatosis and kidney inflammation

### Example 3-2: Metabolic Dysfunction Alleviating Effect of bvPLA2

- investigate effects of bvPLA2 on liver and kidney functions

## Example 4: Effect of bvPLA2 of Inhibiting Macrophage Infiltration in Adipose Tissue

- investigate PLA2 inhibiting macrophage infiltration in WAT

## Example 5: Effects of bvPLA2 of Modulating M1 or M2 Phenotype Markers and Adipogenic Factors

- analyze changes in macrophage phenotypes

### Example 6: Comparison with Mellitin in Bee Venom

- compare mellitin with bvPLA2 in obesity inhibitory effect

